180 related articles for article (PubMed ID: 8728079)
1. Use of a gonadotropin-releasing hormone agonist in the evaluation of postmenopausal virilization due to ovarian hyperthecosis. A case report.
Koroscil TM; Harter SB; Ouweleen J; Blauer KL
J Reprod Med; 1996 Apr; 41(4):259-62. PubMed ID: 8728079
[TBL] [Abstract][Full Text] [Related]
2. Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and "add-back" therapy.
Murray SC; Muse KN
Fertil Steril; 1997 Feb; 67(2):390-3. PubMed ID: 9022620
[TBL] [Abstract][Full Text] [Related]
3. Virilization and Enlarged Ovaries in a Postmenopausal Woman.
Guerrero J; Marcus JZ; Heller DS
Int J Surg Pathol; 2017 Sep; 25(6):507-508. PubMed ID: 28585475
[TBL] [Abstract][Full Text] [Related]
4. Virilization due to ovarian hyperthecosis in a postmenopausal woman.
van Heyningen C; MacFarlane IA; Diver MJ; Muronda C; Tuffnell D
Gynecol Endocrinol; 1988 Dec; 2(4):331-8. PubMed ID: 3232554
[TBL] [Abstract][Full Text] [Related]
5. [Virilization of a post-menopausal woman. Diagnostic and therapeutic considerations].
Montoya T; Guijarro G; Elvira R; Olivar J
Endocrinol Nutr; 2009 Oct; 56(8):422-7. PubMed ID: 19959153
[TBL] [Abstract][Full Text] [Related]
6. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
[TBL] [Abstract][Full Text] [Related]
7. Virilization due to ovarian androgen hypersecretion in a patient with ectopic adrenocorticotrophic hormone secretion caused by a carcinoid tumour: case report.
Netea-Maier RT; Nieuwlaat WA; Sweep CG; Wesseling P; Massuger L; Hermus AR
Hum Reprod; 2006 Oct; 21(10):2601-5. PubMed ID: 16772282
[TBL] [Abstract][Full Text] [Related]
8. [Virilization in women. Clinical and therapeutic aspects].
Molinatti GM; Messina M; Monaco A; Passera P
Minerva Endocrinol; 1993 Mar; 18(1):1-11. PubMed ID: 8232116
[TBL] [Abstract][Full Text] [Related]
9. Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy.
Mizutani T; Sugihara A; Honma H; Komura H; Nakamuro K; Terada N
Gynecol Endocrinol; 2005 Feb; 20(2):80-3. PubMed ID: 15823826
[TBL] [Abstract][Full Text] [Related]
10. Medical treatment of uterocutaneous fistula with gonadotropin-releasing hormone agonist administration.
Seyhan A; Ata B; Sidal B; Urman B
Obstet Gynecol; 2008 Feb; 111(2 Pt 2):526-8. PubMed ID: 18239009
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy after unilateral oophorectomy in a woman with hyperthecosis ovarii. A case report.
Rezai P; Lui P
J Reprod Med; 1994 Sep; 39(9):729-32. PubMed ID: 7807488
[TBL] [Abstract][Full Text] [Related]
12. Benign symptomatic hyperandrogenism in a postmenopausal woman.
Cowan BD; Moore JL; Whitworth NS; Wiser WL
Geriatrics; 1991 Dec; 46(12):57-8, 63. PubMed ID: 1743531
[TBL] [Abstract][Full Text] [Related]
13. Postmenopausal hyperthecosis: functional dysregulation of androgenesis in climacteric ovary.
Krug E; Berga SL
Obstet Gynecol; 2002 May; 99(5 Pt 2):893-7. PubMed ID: 11975949
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone agonist treatment in postmenopausal women with hyperandrogenism of ovarian origin.
Vollaard ES; van Beek AP; Verburg FA; Roos A; Land JA
J Clin Endocrinol Metab; 2011 May; 96(5):1197-201. PubMed ID: 21307133
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
Elkind-Hirsch KE; Anania C; Malinak R
J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
[TBL] [Abstract][Full Text] [Related]
16. Virilization persists in a woman with an androgen-secreting granulosa cell tumor.
Patel SS; Carrick KS; Carr BR
Fertil Steril; 2009 Mar; 91(3):933.e13-5. PubMed ID: 19062005
[TBL] [Abstract][Full Text] [Related]
17. Postmenopausal virilization after spousal use of topical androgens.
Merhi ZO; Santoro N
Fertil Steril; 2007 Apr; 87(4):976.e13-5. PubMed ID: 17254577
[TBL] [Abstract][Full Text] [Related]
18. Steroidogenic acute regulatory protein in ovarian follicles of gonadotropin-stimulated rats is regulated by a gonadotropin-releasing hormone agonist.
Irusta G; Parborell F; Peluffo M; Manna PR; Gonzalez-Calvar SI; Calandra R; Stocco DM; Tesone M
Biol Reprod; 2003 May; 68(5):1577-83. PubMed ID: 12606484
[TBL] [Abstract][Full Text] [Related]
19. Postmenopausal virilization in a woman with gonadotropin dependent ovarian hyperthecosis.
Manieri C; Di Bisceglie C; Fornengo R; Grosso T; Zumpano E; Calvo F; Berardengo E; Volante M; Papotti M
J Endocrinol Invest; 1998 Feb; 21(2):128-32. PubMed ID: 9585388
[TBL] [Abstract][Full Text] [Related]
20. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
